CA
Cormorant Asset Management, LP disclosed a 5.1% stake in RAPP
Cormorant Asset Management, LP reported owning 5.1% of Rapport Therapeutics, Inc. (RAPP) (2,457,521 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G